Endodiag {PNG}EndoDiag, a Genopole company specializing in the development of innovative solutions for the diagnosis of endometriosis, has recently raised €4 million from CM-CIC Innovation and BNP Paribas Development.

Endodiag has a portfolio of innovative diagnostic products used in personalized medicine approaches.
"We are delighted to welcome CM-CIC Innovation and BNP Paribas Development alongside our historic investor Medevice Capital to accompany us in this phase of acceleration and preparation for market entry", said Cécile Real, Co-Founder and President of Endodiag.

Part of the funds raised will be used to complete clinical validation of EndoDtect®, Endodiag’s product that targets diagnosis of endometriosis from a single blood test, to prepare its marketing and to continue the development of other projects in the portfolio.

"This fundraising program allows us to accelerate the clinical validation of our projects and the opportunity to significantly improve the quality of life for millions of women affected by this disease, through a simpler and faster diagnosis and better medical care of the disease", added Cécile Real.